Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Pandita

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Genes, Chromosomes & Cancer|December 4, 2002
Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomasJane Bayani, Maria Zielenska, Ajay Pandita, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
Cancer Research|July 3, 2008
Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancerCarol O'Brien, Guy Cavet, Ajay Pandita, et al.
Cancers|February 13, 2026
Real-Time Therapy Response Monitoring Using Surface Biomarkers on Circulating Tumor CellsSaloni Andhari, Jaspreet Farmaha, Ashutosh Vashisht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation responseJann N Sarkaria, Brett L Carlson, Mark A Schroeder, et al.
Plos One|September 15, 2010
Molecular biomarker analyses using circulating tumor cellsElizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, et al.
Molecular Cancer Research : MCR|August 13, 2009
Oncogenic activating mutations are associated with local copy gainBarmak Modrek, Lin Ge, Ajay Pandita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Nature|May 17, 2011
COP1 is a tumour suppressor that causes degradation of ETS transcription factorsAlberto C Vitari, Kevin G Leong, Kim Newton, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Genes, Chromosomes & Cancer|December 4, 2002
Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomasJane Bayani, Maria Zielenska, Ajay Pandita, et al.
Cancer Discovery|March 6, 2012
Durable complete response of metastatic gastric cancer with anti-Met therapy followed by resistance at recurrenceDaniel V T Catenacci, Les Henderson, Shu-Yuan Xiao, et al.
Cancer Research|July 3, 2008
Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancerCarol O'Brien, Guy Cavet, Ajay Pandita, et al.
Cancers|February 13, 2026
Real-Time Therapy Response Monitoring Using Surface Biomarkers on Circulating Tumor CellsSaloni Andhari, Jaspreet Farmaha, Ashutosh Vashisht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 13, 2006
Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation responseJann N Sarkaria, Brett L Carlson, Mark A Schroeder, et al.
Plos One|September 15, 2010
Molecular biomarker analyses using circulating tumor cellsElizabeth A Punnoose, Siminder K Atwal, Jill M Spoerke, et al.
Molecular Cancer Research : MCR|August 13, 2009
Oncogenic activating mutations are associated with local copy gainBarmak Modrek, Lin Ge, Ajay Pandita, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 9, 2012
Phosphoinositide 3-kinase (PI3K) pathway alterations are associated with histologic subtypes and are predictive of sensitivity to PI3K inhibitors in lung cancer preclinical modelsJill M Spoerke, Carol O'Brien, Ling Huw, et al.
Nature|May 17, 2011
COP1 is a tumour suppressor that causes degradation of ETS transcription factorsAlberto C Vitari, Kevin G Leong, Kim Newton, et al.
British Journal of Cancer|September 18, 2015
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patientsElizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, et al.
Pageof 3